| Study |
Reference |
|
Huybrechts (Controls unexposed, NOS), 2023
|
Huybrechts The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study Pharmacoepidemiol Drug Saf 2021; 30 Suppl 1:3-439 Huybrechts Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry 2023; 80:156-166 Huybrechts Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry 2016; 73:938-46
|
|
Huybrechts (Controls unexposed, sick), 2023
|
Ellfolk Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol 2021; 77:1737-1745 Huybrechts The impact of in-utero antipsychotic drug exposure on congenital malformations: An international cohort study Pharmacoepidemiol Drug Saf 2021; 30 Suppl 1:3-439 Huybrechts Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry 2023; 80:156-166
|
|
Kulkarni, 2024
|
Kulkarni Clozapine Safety in Pregnancy: A Clinical Study. Schizophr Bull 2024; :
|
|
McKenna, 2005
|
McKenna K Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005;66:444-9; quiz 546
|
|
Peng, 2013
|
Peng M Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology (Berl) 2013;228:577-84
|
|
Reis (Control exposed to FGA), 2008
|
Reis M Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008;28:279-88
|
|
Reis (Unexposed control, NOS), 2008
|
Reis M Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 2008;28:279-88
|
